Alternative sigma factor over-expression enables heterologous expression of a type II polyketide biosynthetic pathway in Escherichia coli

PLoS One. 2013 May 28;8(5):e64858. doi: 10.1371/journal.pone.0064858. Print 2013.

Abstract

Background: Heterologous expression of bacterial biosynthetic gene clusters is currently an indispensable tool for characterizing biosynthetic pathways. Development of an effective, general heterologous expression system that can be applied to bioprospecting from metagenomic DNA will enable the discovery of a wealth of new natural products.

Methodology: We have developed a new Escherichia coli-based heterologous expression system for polyketide biosynthetic gene clusters. We have demonstrated the over-expression of the alternative sigma factor σ(54) directly and positively regulates heterologous expression of the oxytetracycline biosynthetic gene cluster in E. coli. Bioinformatics analysis indicates that σ(54) promoters are present in nearly 70% of polyketide and non-ribosomal peptide biosynthetic pathways.

Conclusions: We have demonstrated a new mechanism for heterologous expression of the oxytetracycline polyketide biosynthetic pathway, where high-level pleiotropic sigma factors from the heterologous host directly and positively regulate transcription of the non-native biosynthetic gene cluster. Our bioinformatics analysis is consistent with the hypothesis that heterologous expression mediated by the alternative sigma factor σ(54) may be a viable method for the production of additional polyketide products.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Base Sequence
  • Benzothiazoles
  • Biosynthetic Pathways*
  • Diamines
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Escherichia coli / metabolism*
  • Escherichia coli Proteins / genetics
  • Escherichia coli Proteins / metabolism*
  • Gene Expression Regulation, Bacterial / drug effects
  • Molecular Sequence Data
  • Organic Chemicals / metabolism
  • Oxytetracycline / biosynthesis
  • Oxytetracycline / chemistry
  • Oxytetracycline / pharmacology
  • Peptides / metabolism
  • Polyketides / chemistry
  • Polyketides / metabolism*
  • Promoter Regions, Genetic / genetics
  • Quinolines
  • RNA Polymerase Sigma 54 / genetics
  • RNA Polymerase Sigma 54 / metabolism*
  • Transcription, Genetic / drug effects

Substances

  • Anti-Bacterial Agents
  • Benzothiazoles
  • Diamines
  • Escherichia coli Proteins
  • Organic Chemicals
  • Peptides
  • Polyketides
  • Quinolines
  • rpoN protein, E coli
  • SYBR Green I
  • RNA Polymerase Sigma 54
  • Oxytetracycline

Grants and funding

This work was supported by NSERC, Ontario Ministry of Research and Innovation, and the University of Ottawa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.